[
    "{\"step_by_step_thinking\": \"Tivantinib is a selective MET inhibitor. MET-high hepatocellular carcinoma is a type of liver cancer that has high levels of MET, a protein that can promote cell growth and survival. Therefore, a drug that inhibits MET, like tivantinib, could potentially be effective against this type of cancer.\", \"answer_choice\": \"A\"}"
]